Table 7.
Predictor | Hazard Ratio | 95% CI | P Value |
---|---|---|---|
Sex | |||
Female | 1.00 | Reference | Reference |
Male | 1.33 | 0.99‐1.80 | 0.058 |
Cirrhosis | |||
No | 1.00 | Reference | Reference |
Yes, Child‐Pugh | |||
Class A | 1.10 | 0.76‐1.58 | 0.611 |
Class B | 1.58 | 1.02‐2.46 | 0.043 |
Class C | 2.26 | 1.18‐4.33 | 0.015 |
AFP per log/mL increase | 1.30 | 1.18‐1.44 | <0.0001 |
UCSF | |||
Within | 1.00 | Reference | Reference |
Beyond | 2.02 | 1.47‐2.78 | <0.0001 |
Antiviral therapy | |||
HBV not treated | 1.00 | Reference | Reference |
HBV treated | 0.62 | 0.40‐0.96 | 0.032 |
HCV not treated | 1.00 | Reference | Reference |
HCV treated | 1.43 | 0.87‐2.34 | 0.161 |
Treatments | |||
OLT | 1.00 | Reference | Reference |
Resection | 2.38 | 1.35‐4.21 | 0.003 |
RFA | 3.38 | 1.88‐6.08 | <0.0001 |
PEI | 5.94 | 1.98‐17.85 | 0.002 |
TACE | 3.80 | 2.22‐6.52 | <0.0001 |
Chemotherapy | 6.34 | 3.02‐13.08 | <0.0001 |
Supportive | 6.45 | 3.82‐10.89 | <0.0001 |
Abbreviations: OLT, orthotopic liver transplantation; PEI, percutaneous ethanol injection.